6533b826fe1ef96bd1283edb

RESEARCH PRODUCT

Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER)

Ampaiwan ChuansumritJens BjerreLisa MichaelsM. NapolitanoPimlak CharoenkwanG. MarianiMuriel Giansily-blaizotUmran CaliskanGuenter AuerswaldCarmen AltisentJørgen IngerslevGiovanni Di MinnoAlberto DolceJean-françois Schved

subject

RegistrieSevere bleedingAdultMalePediatricsmedicine.medical_specialtyTime FactorsTime FactorAdolescentFactor VII DeficiencyPROPHYLAXIS FACTOR VII DEFICIENCYFactor VIIachemistry.chemical_compoundPlasmaYoung AdultMedicineHumansRegistriesYoung adultFactor VII deficiencyChildFactor VIIbusiness.industryInfantHematologyRecombinant ProteinFactor VIIMiddle Agedmedicine.diseaseThrombosisRecombinant ProteinsClinical trialTreatment OutcomechemistryTreatment evaluationWeekly doseChild PreschoolFemaleOriginal Articles and Brief ReportsbusinessHuman

description

WOS: 000319897700018

yearjournalcountryeditionlanguage
2013-01-01
10.3324/haematol.2012.074039https://hdl.handle.net/20.500.12395/29755